Assessment of Platelet Indices in Patients with Neurodegenerative Diseases: Mean Platelet Volume Was Increased in Patients with Parkinson’s Disease
Table 1
Demographic and clinical characteristics of participants.
Characteristics
Group
Median
Min–Max
P value
Gender (male/female)
AD
40/49*
0.25
PD
46/47*
Control
59/45*
Age (year)
AD
75
46–88
0.052
PD
73
55–87
Control
72
60–86
Platelet count × 103/mm3
AD
237
122–467
0.64
PD
230
102–561
Control
250
143–470
Fasting blood glucose level (mg/dL)
AD
103.5
80–184
0.56
PD
104
77–271
Controls
110.5
75–288
Total cholesterol level (mg/dL)
AD
114
86–174
0.06
PD
105
66–172
Controls
95
79–172
Number of the patients with hypertension (+/−)
AD
29/60*
0.003
PD
38/55*
Control
15/89*
Number of the patients with hyperglycemia (+/−)
AD
18/71*
0.004
PD
25/68*
Control
6/98*
Number of the patients with hypercholesterolemia (+/−)
AD
7/82*
0.81
PD
16/77*
Control
10/94*
Number of the patients with antidepressant use (+/−)
AD
35/54*
<0.001
PD
34/59*
Control
0/98*
MMSE score
AD
18
6–26
HYS score
PD
2
1–4
Number of the patients; (+/−): present/not present; MMSE: minimental state examination; HYS: Hoehn and Yahr scale; AD: Alzheimer’s disease; PD: Parkinson’s disease.
